UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis

Table 1

Characteristics of studies included in the meta-analysis.

First author	Year	Country	Ethnicity	Samples size (case/control)	OR (95% CI)	Source of controls	Genotyping method^c
Setlur [23]	2010	Austria	Caucasians	121/205	0.88 (0.45–1.73)^a	Hospital based	PCR
Karypidis [24]	2008	Sweden	Caucasians	174/161	2.07 (1.32–3.25)^a	Hospital based	RT PCR
Olsson et al. [25]	2008	Sweden	Caucasians	2,480/1,672	1.01 (0.83–1.23)^b	Population based	Multiplex PCR
Park [26]	2007	USA	Whites	247/273	1.7 (1.03–2.9)^a	Hospital based	PCR-RFLP
Gallagher [27]	2007	USA	Caucasians	411/397	0.97 (0.73–1.30)^a	Hospital based	RT PCR
Park [28]	2006	USA	Caucasian	293/367	1.9 (1.2–3.0)^a	Hospital based	RT PCR
			African Americans	113/115	1.3 (0.6–2.7)^a

aAdjusted odds ratio (OR) and 95% confidence interval (CI).
bUnadjusted odds ratio (OR) and 95% confidence interval (CI).
cGenotyping method—PCR: polymerase chain reaction, RT-PCR: real-time polymerase chain reaction, and PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism.